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Summary  
Pulsed electromagnetic fields (PEMF) influence the extracellular matrix metabolism of a diverse range of skeletal 
tissues. This study focuses upon the effect of PEMF on the composition and molecular structure of cartilage 
proteoglycans. Sixteen-day-old embryonic hick sterna were explanted to culture and exposed to a PEMF for 3 h/day 
for 48 h. PEMF treatment did not affect he DNA content of explants but stimulated elevation of glycosaminoglycan 
content in the explant and conserved the tissue's histological integrity. The glycosaminoglycans in terna exposed to 
PEMF were indistinguishable from those in controls in their composition of chondroitin sulfate resulting from 
chondroitinase ABC digestion. Specific examination with PSI-sulfate labels showed that PEMF treatment significantly 
suppressed both the degradation ofpre-existing glycosaminoglycans biosynthetically abeled in ovo and the synthesis 
of new PSI-sulfated glycosaminoglycans. The average size and aggregating ability of pre-existing and newly synthesized 
[35S]-sulfated proteoglycans extracted with 4 M guanidinium chloride from PEMF-treated cartilage explants were 
identical to controls. The chain length and degree of sulfation of PSI-sulfated glycosaminoglycans lso were identical 
in control and PEMF-treated cultures. PEMF treatment also reduced the amount of both unlabeled glycosaminoglycans 
and labeled pre-existing and newly synthesized pS]-sulfated glycosaminoglycans recovered from the nutrient media. 
[35S]-Sulfated proteoglycans released to the media of both control and PEMF-treated cultures were mostly degradation 
products although their glycosaminoglycan chain size was unchanged. These results demonstrate hat exposure of 
embryonic hick cartilage explants to PEMF for 3 h/day maintains a balanced proteoglycan composition by 
down-regulating its turnover without affecting either molecular structure or function. 
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I n t roduct ion  
CARTILAGE EXTRACELLULAR MATRIX establishes a 
highly concentrated gel of proteoglycan immobi- 
lized within a dense network of collagen fibrils [1]. 
Proteoglycans are high molecular weight mol- 
ecules composed of a core protein to which a large 
number of negatively charged and extremely 
hydrophilic glycosaminoglycan chains are attached 
covalently. Under normal physiological conditions 
sulthted proteoglycans interact with hyaluronic 
acid through one end of the protein core to form 
large multimolecular aggregates [2--4]. The high 
concentration and extreme hydrophilicity of pro- 
teoglycan aggregates create swelling pressure 
within the extracellular matrix which is con- 
strained by a relatively inextensible collagen 
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network. The association between proteoglycans 
and collagens provides art icular cartilage with the 
unique physical properties of reversible compress- 
ibility and tensile strength enabling it to both 
withstand mechanical stress and protect under- 
lying bone [5]. Loss ofproteoglycan ssociated with 
osteoarthrit is results in a disruption of carti lage 
integrity and an inevitable loss of biomechanical 
function [6]. Maintenance and/or restoration of a 
functional extracellular matrix is of significant 
interest o the repair o f  damaged cartilage. 
Pulsed electromagnetic fields (PEMF) promote 
fracture healing and are widely applied to the 
successful clinical treatment of delayed- or non- 
union fracture in patients [7-12]. Although the 
biological mechanism of action of electrically 
induced osteogenesis is unclear, PEMF is generally 
thought o stimulate ndochondral ossification by 
initiating a series of events in cartilage. Consider- 
able evidence has accumulated indicating that 
PEMF affects the cytodifferentiation a d pheno- 
typic expression of cartilage in vitro [13-15] and 
63 
64 Liu et al.: PEMF effects on cart i lage proteoglycans 
in vivo [16-17]. Of particular interest is the 
ability of PEMF to modulate cartilage extra- 
cellular matrix composition. In most studies, 
proteoglycan content and/or synthesis is elevated 
in response to PEMF treatment [16,18-21]. 
However, in other studies glycosaminoglycan 
synthesis is decreased [22-24] or unaffected [25]. 
Conflicting effects of PEMF on collagen metab- 
olism [19, 22-24], alkaline phosphatase activity 
[23, 26], cell differentiation [15, 22-23, 25, 26], cyclic 
AMP synthesis [26-27] and calcium incorporation 
[13, 15-16, 28] have also been reported. Such a 
wide variation in results can be attributed to 
the diversity of both PEMF driving signals 
employed and range of applications. Similarly, 
many different culture models of cartilage have 
been studied, including embryonic hick sternum 
or limb bud, rat or rabbit costal chondral junction, 
rabbit, bovine or human articular cartilage or 
bovine growth plate etc. Nevertheless, such 
responses suggest that with the appropriate signal 
and targeted cell population, PEMF could 
modulate cartilage extracellular matrix by influ- 
encing chondrocyte behavior. In recent studies, 
PEMF has been shown to preserve cartilage 
extracellular matrix integrity [29-31] and stimu- 
late cartilage extracellular matrix restoration by 
mature bovine joints [21] and human osteoarthritic 
cartilage explants [32]. The preliminary clinical 
application of PEMF stimulation to some articular 
cartilage diseases is encouraging [33]. There 
is no evidence that PEMF evokes the appearance 
of abnormal cell phenotypes within a treated 
population. 
Previously we have investigated the influence of 
different PEMF forms and treatment regimens on 
cell proliferation and sulfated glycosaminoglycan 
synthesis and degradation by embryonic chick 
sternal cartilage xplanted to culture [29-31]. The 
results demonstrate that PEMF is capable of 
modulating the extracellular matrix composition 
of developing cartilage explants by suppressing 
both degradation and synthesis of sulfated gly- 
cosaminoglycans and these effects are dose-related 
[31~-31]. The present studies have further analyzed 
the optimal treatment regimen, 3 h/day, of one 
PEMF signal [31] on the turnover of both total and 
[3aS]-sulfated glycosaminoglycans d the structure 
of pS]-sulfated proteoglycans in embryonic hick 
sternal cartilage explanted to culture. Results 
confirmed previous findings and further demon- 
strated that the decreased synthesis and degra- 
dation of sulfated glycosaminoglycans are 
accompanied by preservation of this component 
within the matrix following PEMF treatment, 
and that the treatment does not affect he structure 
and function of either newly synthesized or 
pre-existing sulfated proteoglycans. 
Mater ia l s  and  Methods  
MATERIALS  
Ham's F12 medium was from Sigma Chemical 
Co., Poole, Dorset, U.K. Fetal calf serum was from 
ICN Flow, Scotland, U.K. Carrier-free [35S/sulfuric 
acid was from Amersham International plc, 
Amersham, U.K. Hyaluronic acid from human 
umbilical cord, chondroitin sulfate from whale or 
shark cartilage, and keratan sulfate from bovine 
cornea were from Sigma Chemical Co. Papain was 
from Hopkin & Williams, Essex, U.K. Chondroitin 
ABC lyase from Proteus vulgaris was from ICN 
Biochemicals, Division of Biochemical Inc., Cleve- 
land, OH, U.S.A. Dimethylmethylene Blue was 
from Aldrich Chemical Co., Gillingham, Dorset, 
U.K. Streptomyces griseus pronase was from 
Boehringer Mannheim, Lewes, East Sussex, U.K. 
Dowex 1 (AG1-X2, 200-400 mesh) was from Bio-Rad 
Laboratories Ltd., Watford, Herts, U.K. Sepharose 
CL-2B and Sephacryl S-200 were from Pharmacia, 
Uppsala, Sweden. DNP-alanine was from Sigma 
Chemical Co. All other reagents were of analytical 
reagent grade. 
ORGAN CULTURE 
Sixteen-day-old White Leghorn embryonic hick 
sternal cartilage was used in all experiments. 
Sterna were dissected free of surrounding and 
adherent tissues in cold calcium- and magnesium- 
free Tyrode's olution, pH 7.4. Equal numbers of 
explants were randomly placed to control and 
experimental culture dishes (plastic tissue, Sterilin 
Ltd, Hounslow, U.K.) according to the experimen- 
tal groups described below. Cultures were main- 
tained in Ham's F12 nutrient medium 
supplemented with 10% fetal calf serum, 1 mM 
glutamine, 0.1 mg/ml ascorbate and 50units/ml 
penicillin and streptomycin (ICN Flow, Scotland, 
U.K.) in a humidified atmosphere at37°C under 5% 
CO2 in air for 48 h [30, 34]. As generally agreed in 
organ culture of embryonic chick cartilage [35-36], 
sternal explants maintain the differentiated pheno- 
type of chondrocytes and readily proliferate and 
increase in size and extracellular matrix content 
with time under the experimental conditions. 
Metabolic activity of the cultured tissue is high 
because of its embryonic nature. However, in terms 
of proteoglycan synthesis, the rate of incorporation 
of [35S]-sulfate is constant with time over the 
indicated incubation period [30]. 
Osteoar thr i t i s  and  Car t i l age  Vol .  4, No .  1 65 ~ 
PEMF TREATMENT 
The apparatus for treatment exposure of cultures 
to PEMF was provided by Electro-Biology, Inc., 
Parsippany, NJ, U.S.A. This apparatus consists of 
an electric control unit and a pair of horizontal ly 
placed circular Helmholtz magnetic coils (14 cm 
diameter, 13 cm intercoil  distance) mounted on a 
plastic framework. The PEMF signal consists of 
30 ms duration bursts of pulses repeated at 1.5 Hz 
[Fig. l(a)]. During each pulse the magnetic field 
rises from 0 to 1 gauss in 230 #s and then returns 
to 0 gauss in 30 #s [Fig. l(b)]. Culture dishes were 
placed between the coils and stacked as close as 
possible to the vertical and horizontal center. 
Experimental cultures were exposed to PEMF for 
3 h/day for the duration of the culture period. This 
treatment was found to be the most effective from 
our previous work [31]. Control cultures were 
maintained within the coils and under identical 
environmental conditions but in the absence of 
PEME 
CONTENT OF GLYCOSAMINOGLYCANS 
Freshly isolated embryonic chick sternal ex- 
plants were placed into 35 mm tissue culture dishes 
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FIG. 1. Schematic representation f the pulsed electro- 
magnetic field. PEMF signal employed in this study 
consists of 30 ms duration bursts of pulses repeated at 
1.5 Hz (a). During each pulse the magnetic field rises 
from 0 to 1 gauss in 230 #s and then returns to 0 gauss 
in 30 ps (b). Sternal cartilage xplanted to culture for 
48 h were exposed to this signal for 3 h per day. 
each containing three sterna and 2 ml of the above 
nutr ient medium. The culture dishes were ran- 
domly designated either control or experimental, 
all in triplicate, and incubated for 48 h in the 
absence or presence of PEMF treatment. Explants 
and media were recovered separately at the end of 
the culture period. Glycosaminoglycans either 
retained by the explants or released into the media 
were analyzed by reaction with dimethylmethylene 
blue following papain digestion [37]. Chondroitin 
sulfate from shark and whale was used as the 
standard to calibrate the assay. Portions of papain 
digest were further treated with chondroitinase 
ABC to determine the proport ion of chondroit in 
sulfate in the mixture [37-38]. 
LABEL ING OF SULFATED GLYCOSAMINOGLYCANS 
To determine the synthesis of sulfated proteogly- 
can in vitro, 5 pCi/ml carrier-free [35S]sulfuric acid 
was added to control and experimental cultures for 
the final 24 h of the 2-day culture period. At the end 
of the culture period, explants and nutr ient media 
were harvested separately and the incorporation of 
[8~S]-sulfate into sulfated proteoglycans analyzed. 
In separate xperiments, 10 pCi carrier-free [35S]- 
sulfuric acid in 100 #l distilled water was adminis- 
tered onto the chorioallantoic membrane through 
a small hole in the egg shell on the sixth day of 
embryonic development. Following administration 
of isotope, the hole in the shell was sealed with 
transparent adhesive tape and eggs were returned 
to the incubator to permit continued evelopment 
[39-40]. Ten days later, the sterna were isolated 
from these biosynthetically radiolabeled embryos 
and analyzed for [35S]-sulfated proteoglycan content 
either immediately or following explant culture for 
2 days in the presence and absence of PEMF. 
Explants and nutr ient media were again harvested 
and analyzed separately. 
TURNOVER OF SULFATED GLYCOSAMINOGLYCANS 
Quantitative analysis of sulfated glycosaminogly- 
can turnover was studied by determining the rates 
of in vitro incorporation of [35S]-sulfate into 
glycosaminoglycans and in vitro breakdown of 
pre-existing [35S]-sulfated glycosaminoglycans la-
beled in ovo as previously described [30, 39]. In both 
synthesis and degradation experiments, each 
sample comprised three sterna which were cul- 
tured in a 35 mm tissue culture dish containing 
2 ml culture medium. All treatments were per- 
formed in at least triplicate. At the end of the 
culture period, PSI-sulfated glycosaminoglycans 
either remaining in the explants or released into 
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the~media were determined by ion exchange 
chromatography on Dowex 1 (1 × 2-400) following 
Streptomyces griseus pronase digestion of the 
samples. 
EXTRACTION OF SULFATED PROTEOGLYCANS 
Separate xperiments were performed to analyze 
the effect of PEMF on the structure and function 
of [~S]-sulfated proteoglycans. Embryonic chick 
sternal cartilage was labeled for the newly 
synthesized and pre-existing sulfated proteogly- 
cans and cultured with or without PEMF 
treatment in essentially the same way as the above 
described methods except that each culture was 
composed of 20 sterna and maintained in a 60 mm 
tissue culture dish containing 10 ml medium. The 
recovered explants were sliced into small pieces 
with a scalpel and extracted twice with 10 times 
their wet weight of 4 M guanidinium chloride in 
0.05 M sodium acetate buffer, pH 5.8, at 4°C for 24 h 
under continuous agitation. Extracts were cen- 
trifuged at 1000 g for 15 min, supernatant retained 
and residues washed once with small volume of 
cold buffered 4 M guanidinium chloride. Extracts 
and residual washes were pooled and the residues 
were digested with papain in 0.05 M phosphate 
buffer, pH 6.5, containing 2mM N-acetylcysteine 
and 2 mM EDTA at 65°C for 2 h [41]. Media, extracts 
and residues were dialyzed against 0.01 M sodium 
acetate buffer, pH 6.8 at 4°C to remove unbound 
[~S]-sulfate and re-associate proteoglycans. Pep- 
statin A (1 ttg/ml), 1,10-phenanthroline (1 mM), 
iodoacetic acid (1 mM), and phenylmethanesulpho- 
nyl fluoride (1 mM) were present as proteinase 
inhibitors in all extraction and dialysis buffers. 
Samples were analyzed for total [35S]-sulfate 
incorporation into sulfated proteoglycans either 
retained within the explants or released into the 
media using an LKB 1214 Rackbeta Liquid 
Scintillation Counter and an aqueous ACSII 
counting scintil lant (Amersham International, 
Amersham, U.K.). 
GEL F ILTRATION CHROMATOGRAPHY 
Molecular size distribution of [35S]-sulfated 
proteoglycans in explants and media was deter- 
mined by gel chromatography on Sepharose 
CL-2B columns (100 cm × 0.66 cm analytical 
column, Whatman, Kent, U.K.) under dissociative 
and associative conditions [42-43]. Under dissocia- 
tive Conditions, 1ml of dialyzed sample was applied 
to the column at room temperature and eluted 
with 0.5 M sodium acetate buffer containing 4 M 
guanidinium chloride, pH 7.0, at 3ml/h. Under 
associative conditions, samples were mixed with 
hyaluronic acid (30 #g/ml) at 4°C for 4 h and then 
eluted with 0.5 M sodium acetate buffer, pH 7.0. 
The size distribution of glycosaminoglycan chains 
was determined by gel chromatography on Sep- 
hacryl S-200 (100 cm× 0.66 cm analytical column, 
Whatman) [44]. Peak fractions eluted from Sepha- 
rose CL-2B columns under associative conditions 
were pooled, digested with papain at 65°C over- 
night, applied to Sephacryl S-200 columns and then 
eluted at room temperature with 0.5 M sodium 
acetate buffer, pH 7.0, at 1.5 ml/h. Fraction of 0.5 ml 
was collected and aliquot analyzed for [35S]- 
sulfate radioactivity. Proteoglycan aggregate and 
DNP-alanine were used as markers of the void (Vo) 
and total (Vt) volumes of the columns. The 
proteoglycan aggregate prepared from pig laryn- 
geal cartilage was a gift from Michael T. Bayliss, 
Kennedy Institute of Rheumatology, London, U.K. 
CELLULOSE ACETATE ELECTROPHORESIS OF 
GLYCOSAMINOGLYCANS 
The degree of sulfation and charge density of 
the sulfated glycosaminoglycans were determined 
by cellulose acetate electrophoresis [45]. Peak 
fractions eluted from the Sephacryl S-200 column 
were pooled, dialyzed against distilled water at 
4°C overnight and lyophilized. Lyophilized samples 
were re-dissolved in distilled water. Duplicate 
samples were spotted onto Cellogel strips 
(57 mm × 140 mm, Whatman, Chemetron, Italy) and 
subjected to electrophoresis in 0.1M KH2PO4/ 
0.1M HC1, pH 2.0, with a potential gradient of 
5 V/cm for 3 h. Hyaluronic acid, chondroitin sulfate 
and keratan sulfate were included as standards. 
Following electrophoresis, one strip was cut into 
0.25cm sections and analyzed for radio- 
activity. The other was stained with 0.02% alcian 
blue in 0.05 M MgC12/0.05 M sodium acetate buffer, 
pH 5.8, for 45 min at room temperature and then 
destained in the same buffer without alcian blue. 
HISTOLOGICAL PROCEDURES 
Sterna from 16-day-old chick embryos either 
freshly dissected or cultured for 48 h in the absence 
or presence of PEMF treatment were fixed for 24 h 
in buffered formaldehyde sublimate. Following 
standard histological procedures, tissues were 
embedded in paraffin wax, serially sectioned at 
7 pm and stained with safranin O and Mayer's 
haematoxylin. 
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FIG. 2. DNA and glycosaminoglycan o tents of explant cultures. Sternal cartilage was explanted to culture for 2 days. 
DNA content (a) and the amount of glycosaminoglycan in the recoveries from explants (b) and media (c) were determined 
at the beginning (day 0) and the end of the experiment (day 2) in either the absence (hatched columns) or presence 
of PEMF (solid columns). All data are expressed as means _ S.D. of at least three measurements. 
OTHER ANALYSES 
DNA content of sternal cartilage was measured 
by a fluorometric method of Royce and Lowther 
[46]. Briefly, aliquot from papain or pronase di- 
gests of cartilage explants prepared in all of the 
above described quantitative experiments was 
pre-treated with RNase from bovine pancreas 
[Sigma Chemical Co.] and then mixed with 
ethidium bromide. The content of DNA was 
estimated from the intensity of fluorescence 
emitted by ethidium bromide intercalated into 
DNA. Statistical analysis was performed using the 
Student's t-test. 
Resu l ts  
EFFECTS OF PEMF ON THE CONTENT OF 
GLYCOSAMINOGLYCANS 
The amount of DNA and glycosaminoglycan in 
the tissue at the beginning (day 0) and the end of 
the experimental treatment (day 2) was determined 
and, together with the amount of glyc0saminogly- 
can released from the explant into the medium, is 
summarized in Fig. 2. Control cultures showed a 
17.5% increase in the amount of DNA content per 
initial wet weight after the culture period under 
the experimental conditions (P< 0.01). PEMF 
treatment of 3 h/day for 2 days did not cause any 
difference from controls in DNA content [Fig. 2(a)]. 
Thus, the observed results to be described are 
all expressed with reference to DNA content to 
avoid artificial effects of each sample's relative 
cellularity. 
Glycosaminoglycan content retained by control 
explants [Fig. 2(b)] was increased by 25.7% after 2 
days in culture (P < 0.05) and glycosaminoglycan 
content released from explants to media during 
the culture period [Fig. 2(c)] was 5.1% of the total. 
After the exposure of cultures to PEMF for the 
same period, glycosaminoglycan content retained 
by the explants was 21.4% higher than in controls 
(P < 0.05) whereas glycosaminoglycans released to 
the media were 30.6% lower compared to controls 
(P < 0.02). As a result, PEMF treatment promoted 
a net production of glycosaminoglycans in the 
matrix of the tissue examined. 
The composition of glycosaminoglycans i  pa- 
pain digests of cartilage xplants was determined 
by chondroitin ABC lyase digestion. Of gly- 
cosaminoglycans from day 0 explant 92.6 ± 0.8% 
(mean±s.D.) were digested with the specific 
enzyme. This proportion of chondroitin sulfate in 
glycosaminoglycans of the tissue examined was 
the same as observed in embryonic hick cartilage 
[36, 40]. After explant culture for 2 days, the 
proportion of the enzyme-digested glycosaminogly- 
cans in all cultures was the same as that of day 0 
and there was no difference in this respect between 
control (92.3 _ 1.5%) and PEMF-treated 
(92.8 ± 1.9) cultures. 
EFFECTS OF PEMF ON PROTEOGLYCAN SYNTHESIS 
Incorporation rate of [85S]-sulfate into sulfated 
glycosaminoglycans 
Embryonic hick sternal cartilage was explanted 
to culture for 48 h in the absence or presence of 
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Fro. 3. Synthesis of [3~S]-sulfated glycosaminoglycans in explant cultures. Sternal cartilage was explanted to culture 
for 2 days in either the absence (hatched columns) or presence (solid columns) of PEMF and incubated with pS]sulfuric 
acid for the final 24 h. The rate of [35S]-sulfate incorporation i to glycosaminoglycans, i dicative of glycosaminoglycan 
synthesis, was calculated as the recoveries of radioactivity from the explants (a) and the media (b). All data are the 
means ± S.D. of at least three measurements. 
PEMF and pS]-sulfate added during the final 24 h. 
The incorporation rate of [~sS]-sulfate into gly- 
cosaminoglycans was determined as a measure 
of proteoglycan synthesis and is shown in Fig. 3. 
It was found that the level of newly syn- 
thesized sulfated glycosaminoglycans recovered 
from PEMF-treated explants was 76.6% lower 
than that from untreated controls (P< 0.001) 
[Fig. 3(a)]. It was also found that the PEMF 
treatment reduced the level of newly synthesized 
glycosaminoglycans recovered from the media 
[Fig. 3(b), P < 0.02]. The reduced release of newly 
synthesized glycosaminoglycans i  PEMF-treated 
cultures appears not to be a consequence of the 
reduced synthetic rate of the molecules ince the 
release rate of  newly synthesized sulfated gly- 
cosaminoglycans from cultured cartilage tissue 
is regulated by a mechanism independent from their 
synthetic rate in cartilage organ culture [47]. These 
data demonstrate that PEMF treatment signifi- 
cantly suppresses the biosynthesis of sulfated 
proteoglycans and their release by embryonic hick 
sternal cartilage xplanted to culture. 
Size distribution and aggregation ability of newly 
synthesized proteoglycans 
Newly synthesized [~S]-sulfated proteoglycans 
were extracted from cultures with 4 M guanidinium 
chloride as described in Methods. This non- 
disruptive procedure resulted in an 83.1-88.3% 
extraction of labeled proteoglycans. The extracts 
were therefore regarded as an effective represen- 
tation of total sulfated proteoglycan content of 
the cartilage explants [48-50] and were subjected 
to structural analysis. Sulfated proteoglycans 
extracted from the explants and recovered from 
the nutrient media were eluted on Sepharose 
CL-2B columns under dissociative and associative 
conditions. Newly synthesized proteoglycans ex- 
tracted from the explants in control cultures 
were eluted as monomers under dissociative 
conditions and showed a broad size distribution 
[Fig. 4(a)] reflecting the polydispersed property 
of normal sulfated proteoglycans [51-52]. Under 
associative conditions, the majority of the 
sulfated proteoglycans aggregated with hyaluronic 
acid and eluted in the void volume. In the 
presence of PEMF, the size distribution and 
aggregation ability of newly synthesized proteo- 
glycans were identical to controls although the 
amount was reduced owing to the suppressive 
effects of PEMF on sulfated proteoglycan synthesis 
[Fig. 4(b)]. The average molecular size of newly 
synthesized proteoglycans released into the 
media in the absence of PEMF was significantly 
reduced compared with that extracted from the 
explants. The majority of pS]-sulfated material 
recovered with the nutrient medium was unable to 
aggregate with hyaluronic acid [Fig. 4(c)], indicat- 
ing that they might be degradation products. 
Proteoglycans released to the nutrient medium in 
the presence of PEMF showed a similar elution 
profile to the controls but the total amount was 
again reduced [Fig. 4(d)]. 
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Fro. 4. Sepharose CL-2B chromatography of newly synthesized [3~S]-sulfated proteoglycans. Sternal cartilage xplants 
were cultured in the absence [(a), (c)] or presence of PEMF [(b), (d)] for 48 h and incubated with [35S]sulfuric acid for 
the final 24 h. Samples of sulfated proteoglycan from 4 • guanidinium chloride extracts [(a), (b)] and media [(c), (d)] 
were dialysed and applied to Sepharose CL-2B columns under associative (open circles) and dissociative (solid circles) 
conditions. Columns were eluted at room temperature at a rate of 3 m/h. Fractions were analyzed for radioactivity. Vo 
and Vt indicate the void volume and the total bed volume of the columns, respectively. 
Size distribution of newly synthesized sulfated 
glycosaminoglycans 
Peak fractions eluted from Sepharose CL-2B 
columns under associative conditions were pooled 
as indicated, digested with papain to generate 
glycosaminoglycan chains and subjected to Sep- 
hacryl S-200 chromatography. The elution profiles 
are shown in Fig. 5. The average molecular size of 
newly synthesized sulfated glycosaminoglycans 
recovered with the explants [Fig. 5(a)] or nutr ient 
media [Fig. 5(b)] was the same in PEMF-treated 
and control cultures although the amount was 
reduced in the presence of PEMF. Newly syn- 
thesized [~S]-sulfated glycosaminoglycans solubil- 
ized from cartilage xplants also were subjected to 
Sephacryl S-200 chromatography and demonstrated 
no difference in the size distribution between 
control and PEMF treated samples (data not 
shown). 
Degree of sulfation of newly synthesized sulfated 
glycosaminoglycans 
Peak Sephacryl S-200 fractions of sulfated 
glycosaminoglycans extracted from explants were 
pooled as indicated, dialyzed, lyophilized and 
subjected to cellulose acetate electrophoresis in
0.1M HC1. The migration distance of sulfated 
glycosaminoglycan chains was identical in either 
the absence or presence of PEMF (Fig. 6). The 
migration rate of individual polysaccharides 
depends exclusively on their degree of sulfation 
under the experimental conditions employed in 
this study [44]. Therefore, the sulfated glycosamino- 
glycans newly synthesized in the presence of 
PEMF were sulfated and charged to the same 
degree as untreated controls. The mobility of 
sulfated glycosaminoglycans from embryonic hick 
sternal cartilage was reduced compared with 
the chondroit in sulfate standard from shark or 
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whale carti lage due to over-sulfation of the latter 
[53-54]. 
EF;EcTs  OF PEMF ON PROTEOGLYCAN DEGRADATION 
Degradation rate of pre-existing proteoglycans 
[~sS]Sulfuric acid was administered onto the 
chorioal lantoic membrane of the 6-day-old chick 
embryos and radiolabeled sterna harvested 10 days 
later. Sterna were either immediately analyzed for 
the level of the [~S]-sulfated glycosaminoglycans or 
explanted to culture in the absence or presence of 
PEMF. The recoveries of [3~S]-sulfated glycosamino- 
glycans from explants and media were summed and 
the percentages of [s~S]-sulfated glycosaminogly- 
cans remaining in the matr ix after culture for 2 
days are shown in Fig. 7. In control  cultures, 
recovery of pre-existing [~sS]-sulfated glycosamino- 
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Fro. 5. Sephacryl S-200 chromatography of newly 
synthesized [~S]-sulfated glycosaminoglycans. Pooled 
proteoglycan fractions were digested with papain and 
applied to Sephacryl S-200 columns. [~S]-Sulfated 
glycosaminoglycans from control (open circles) and 
PEMF-treated (solid circles) cultures were eluted at 
room temperature with 0.5 M sodium acetate, pH 7.0, at 
a rate of 1.5 m/h. Fractions were analyzed for radioac- 
tivity. Vo and V~ indicate the void volume and the total 
bed volume of the columns, respectively. (a): extract, (b): 
medium. 
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acetate Fro. 6. Cellulose electrophoresis of newly 
synthesized [35S]-sulfated glycosaminoglycans. Pooled 
glycosaminoglycan fractions were dialyzed, lyophilized 
and subjected to electrophoresis. Samples from control 
(open circles) and PEMF-treated (solid circles) cultures 
were run on cellulose acetate strips in 0.1 M KH~PO~/ 
0.1 M HC1, pH 2.0, with a potential gradient of 5 V/cm for 
3 h. Hyaluronic acid, chondroitin sulfate and keratan 
sulfate were included as standards. Strips were either 
stained with alcian blue, denoted by the bars, or 
sectioned and analyzed for radioactivity. 
glycans from the explants was 86.1%. Fol lowing 
t reatment  with PEMF over the same period 93.9% 
of the pre-existing pS]-sulfated glycosaminogly- 
cans were recovered from the explants (P < 0.05). 
These results demonstrate that PEMF treatment 
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FIG. 7. Degradation of pre-existing [35S]-sulfated gly- 
cosaminoglycans in explant cultures. Sterna were 
isolated from embryos previously administered with 
['~'~S]sulfuric a id in ovo. The fate of the pre-existing 
pS]-sulfated glycosaminoglycans after 2 days culture in 
the absence (hatched column) or presence (solid column) 
of PEMF was determined and expressed as percentage of
radioactivity retained by the explant. All data are the 
means ± S.D. of at least three measurements. 
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FIG. 8. Sepharose CL-2B chromatography of pre-existing [35S]-sulfated proteoglycans. Sterna isolated from embryos 
previously administered with pS]sulfuric acid were explanted to culture in the absence [(a), (c)] or presence of PEMF 
[(b), (d)] for 48 h. Samples of sulfated proteoglycan from 4 M guanidinium chloride xtracts [(a), (b)] and media [(c), (d)] 
were dialysed and applied to Sepharose CL-2B columns under associative (open circles) and dissociative (solid circles) 
conditions. Columns were eluted at room temperature at a rate of 3 m/h. Fractions were analyzed for radioactivity. Vo 
and Vt indicate the void volume and the total bed volume of the columns, respectively. 
significantly suppresses the  in ovo-labeled pre-ex- 
isting sulfated proteoglycans of chick sternal 
cartilage from breakdown and release. 
Size distribution, aggregation ability and degree of 
sulfation of pre-existing proteoglycans 
Like the newly synthesized sulfated proteogly- 
cans in vitro, about 90-92% of the in ovo-labeled 
pre-existing sulfated proteoglycans were extracted 
with 4 M guanidinium chloride from the tissue and 
they displayed very similar structural characteriz- 
ations. Fig. 8 shows that the size distribution and 
aggregation ability of pre-existing sulfated proteo- 
glycans in the presence of PEMF exhibited the 
same average molecular size and ability to 
re-aggregate as those in the absence of PEMF, and 
that the average molecular size and aggregation 
ability of pre-existing sulfated proteoglycans re- 
leased into the media by control and PEMF- 
treated cultures also were similar. There was no 
difference in average length of pre-existing sulfated 
glycosaminoglycans retained by the explants or 
released into the medium in control and PEMF- 
treated cultures (Fig. 9), nor in their degree of 
sulfation or charge density (Fig. 10). These data 
demonstrate further that PEMF treatment sup- 
presses the degradation of sulfated proteoglycans 
by embryonic hick cartilage explanted to culture 
without affecting their molecular structure or 
behavior. 
EFFECTS OF PEMF ON HISTOLOGICAL ORGANIZATION OF 
CARTILAGE 
The histological appearance of sternal carti lage 
either freshly dissected or cultured for 48 h in the 
absence or presence of PEMF treatment is shown 
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in Fig. 11. Immediately following isolation, chick 
sternal cartilage showed the characteristic appear- 
ance of developing hyaline cartilage [Fig. 11(a)]. 
Ch6ndrocytes were flattened on the surface of 
sternum and rounded and uniformly distributed at 
deeper levels. The matrix was intensely and 
uniformly stained with safranin O throughout the 
full thickness of the keel of the sternum. After 48 h 
of control culture, the deep chondrocytes were 
slightly randomly distributed and matrix staining 
was both weaker and heterogenous [Fig. 11(b)]. 
Following 48 h culture in the presence of PEMF, 
the morphology and distribution of chondrocytes 
did not change and the entire extracellular matrix 
staining was intense, although discrete deep areas 
were less uniformly stained [Fig. 11(c)]. Safranin O 
binds stoichiometrically to either chondroitin 
sulfate or keratan sulfate in an equivalence ratio 
very close to one: one molecule of safranin O 
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FIG. 9. Sephacryl S-200 chromatography of pre-existing 
[35S]-sulfated glycosaminoglycans. Pooled proteoglycan 
fractions were digested with papain and applied to 
Sephacryl S-200 columns. [35S]-sulfated glycosaminogly- 
cans from control (open circles) and PEMF-treated (solid 
circles) cultures were eluted at room temperature with 
0.5M sodium acetate, pH 7.0, at a rate of 1.5m/h. 
Fractions were analyzed for radioactivity. Vo and Vt 
indicate the void volume and the total bed volume of the 
columns, respectively. (a): extract, (b): medium. 
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Fro. 10. Cellulose acetate electrophoresis of newly 
synthesized [asS]-sulfated glycosaminoglycans. Pooled 
glycosaminoglycan fractions were dialysed, lyophilized 
and subjected to electrophoresis. Samples from control 
(open circles) and PEMF-treated (solid circles) cultures 
were run on cellulose acetate strips in 0.1 M KH2PO~/ 
0.1 M HC1, pH 2.0, with a potential gradient of 5 V/cm for 
3 h. Hyaluronic acid, chondroitin sulfate and keratan 
sulfate were included as standards. Strips were either 
stained with alcian blue, denoted by the bars, or 
sectioned and analyzed for radioactivity. 
binds to each negatively charged group of either 
polyanion [55]. The extracellular concentration of
the dye is proportional to the concentration of 
glycosaminoglycan. I tense and uniform staining 
of cartilage extracellular matrix with safranin O 
in histological section of PEMF-treated sternum 
was in agreement with the quantitative measure- 
ment of glycosaminoglycans in the matrix and 
confirmed the finding that PEMF treatment 
conserves in vitro the extracellular matrix in- 
tegrity of embryonic hick cartilage in terms of 
proteoglycan composition. 
Discuss ion  
Cultured cartilage explants provide an efficient 
model system with which to investigate the 
influence and mechanism of action of various 
factors on the synthesis and degradation of 
extracellular matrix components [56]. Organ cul- 
ture of cartilage has numerous advantages over cell 
culture of isolated chondrocytes: in explant culture 
the extracellular matrix is intact, chondrocytes 
maintain their differentiated state and are not 
exposed to the extensive proteolytic activity 
required for their dissociation [57-58]. 
Using embryonic chick sternal cartilage ex- 
planted to  culture, we have previously studied 
the effect of PEMF on the metabolism of sulfated 
glycosaminoglycans in cartilage extracellular 
matrix. The results showed that PEMF modulates 
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FIG. 11. The histological organization of freshly isolated 
sternum (a) comparedwith sterna explanted to culture 
for 48 h in the absence (b) and presence (c) of PEMF. 
Tissues were processed to paraffin wax and serial 6 pm 
sections tained with safranin O and Mayer's haematoxy- 
lin (×250). 
sulfated glycosaminoglycan turnover by embryonic 
chick sternal cartilage explanted to culture 
[29-31]. Treatment with PEMF reduced degra- 
dation of pre-existing sulfated glycosamino- 
glycans, the synthesis of new sulfated 
glycosaminoglycans and the release of gly- 
cosaminoglycans from the explants. Each of these 
effects was significant within 48h and was 
enhanced in the presence of retinoic acid [29-30]. 
The effects of PEMF on embryonic chick ster- 
nal cartilage explanted to culture had also been 
shown to be influenced by both the signal form 
and the frequency of treatment [30-31]. In this 
study, we have focused on the optimal treatment 
regimen of one PEMF signal [31] and investi- 
gated its effects further. We have shown that 3 h 
treatment per day for 2 days significantly in- 
creases the recovery of pre-existing [35S]-sulfated 
proteoglycans retained by the explants and this 
is matched by a reduced synthetic rate of 
[35S]-sulfated proteoglycans. We have also shown 
both quantitatively and qualitatively that PEMF 
treatment promotes deposition of glycosaminogly- 
cans in the matrix. Since DNA content of the 
cultures was not affected by the PEMF exposure, 
the observed effects of PEMF are one of direct 
modulation of chondrocyte activity rather than a 
result of enhanced cellular proliferation. 
A consistent finding in the present study is that 
PEMF treatment prevented the release of both 
unlabeled glycosaminoglycans and labeled newly 
synthesized and pre-existing sulfated glycosamino- 
glycans from the matrix. It seems that PEMF did 
not act to slow down the rate of turnover of 
glycosaminoglycan by suppressing chondrocyte 
activity since proteoglycan catabolism is a well- 
known chondrocyte-mediated process [43, 59-60]. 
In addition, PEMF stimulated a significant amount 
of glycosaminoglycan deposition within the carti- 
lage matrix. Therefore, the decrease in the rate of 
[35S]-sulfate incorporation may not be by direct 
inhibition of PEMF on the pathway ofglycosamino- 
glycan synthesis but by a secondary reaction 
regulated by reduced release of this component 
from the matrix. This proposal is supported by a 
general understanding of the regulation of carti- 
lage extracellular matrix. Studies indicate that the 
homeostatic maintenance of proteoglycan mol- 
ecules is dependent upon their co-ordinated 
synthesis and degradation by chondrocytes. The 
activation of proteoglycan synthesis by loss of this 
molecule from the tissue has been widely observed 
in organ cultures of embryonic hick cartilage [36] 
and young or mature mammalian articular carti- 
lage [60-63] and in human and experimental 
osteoarthrosis [64-66]. In contrast, addition of 
proteoglycan to the cultures inhibited its synthesis 
[60]. As reported for many cartilage explant 
cultures, our unpublished experiments in the same 
culture system maintained for up to 8 days revealed 
that the embryonic hick sternal cartilage under- 
went initial adapti0n to culture. During the culture 
period, synthesis of glycosaminoglycans was 
markedly stimulated to replace initial rapid loss of 
this component from the tissue. The synthesis then 
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gxadually lowered to a constant level in response to 
the lowered and stabilized release of glycosamino- 
glycans. This observation further supports the 
proposal that the prevention of release of gly- 
cosaminoglycans from the tissue by PEMF treat- 
ment resulted in the decrease in synthesis of the 
molecules. A different PEMF signal has also been 
found to conserve newly synthesized proteoglycans 
within the matrix of bovine articular cartilage 
explanted to culture [67]. Thus, unlike agents uch 
as retinol [68] and interleukin 1 [47] which induce 
a net depletion of cartilage proteoglycan by 
decreasing synthesis and increasing release of 
sulfated glycosaminoglycans, PEMF conserves 
developing cartilage xtracellular matrix. 
It can be considered that the [~sS]-sulfate label in 
pre-existing sulfated proteoglycans extracted from 
the explants is uniformly incorporated after 
incubation for 10 days in ovo and 2 days in vitro. 
The pre-existing [35S]-sulfated proteoglycans thus 
are interpreted torepresent native components laid 
down in the sternal extracellular matrix. Chroma- 
tography of 4 M guanidinium chloride extracts on 
Sepharose CL-2B demonstrated that the PEMF 
does not affect either the average size of 
pre-existing proteoglycan monomers or their abil- 
ity to aggregate with hyaluronate. Chromatography 
of papain digests of 4M guanidinium chloride 
extracts on Sephacryl S-200 followed by cellulose 
acetate electrophoresis revealed that pre-existing 
glycosaminoglycan chain length and degree of 
sulfation also are unaffected. 
The apparent decrease in sulfated proteoglycan 
synthesis in the presence of PEMF could result 
from a decreased number of normal proteoglycan 
molecules. Alternatively, there could be fewer 
sulfated glycosaminoglycan chains per monomer, or 
the chains could be shorter or under-sulfated. The 
ability of sulfated proteoglycan to aggregate with 
hyaluronic acid also could be perturbed. The 
present studies show that the proteoglycans 
synthesized in the presence of PEMF exhibit the 
same molecular size and that their ability to bind 
to hyaluronic acid and charge density is not 
affected by PEMF treatment. 
The molecular size of either pre-existing or 
newly synthesized [35S]-sulfated proteoglycans re- 
leased to the nutrient medium in the absence or 
presence of PEMF is consistently smaller. Material 
released to the nutrient medium is largely unable 
to aggregate with hyaluronic acid indicating that 
i t  possibly constitutes degradation products. How- 
ever,' the chain length of [~sS]-sulfated glycosamino- 
glycan recovered with the medium or explant is not 
significantly different from one another, indicating 
that there is no significant degradation of 
glycosaminoglycan chains. These proteoglycan 
fragments mainly diffuse out of the matrix, possibly 
because the monomers have a non-functional 
binding region [43]. 
Treatment for 3 h/day with the PEMF employed 
clearly conserves the sulfated proteoglycan content 
of embryonic hick sternal cartilage xplanted to 
culture without affecting sulfated proteoglycan 
structure or function. If such an effect also occurs 
in articular cartilage, PEMF could exert beneficial 
therapeutic potential for the treatment of cartilage 
disorders, such as osteoarthrosis, n which proteo- 
glycan loss is usually progressive [65, 69]. However, 
it is recognized that the effects of PEMF are highly 
signal and tissue-specific [70]. Thus, further 
evidence is needed to illustrate whether the normal 
or osteoarthritic articular cartilage in mammals 
will respond to the present signal and treatment 
regimes in the same way. 
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